×
Please click
here
if you are not redirected within a few seconds.
All
News
Videos
Images
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
BerGenBio ASA Completes Reverse Share Split - TipRanks.com
Tipranks
BerGenBio ASA (BRRGD) has released an update. BerGenBio ASA, a Norwegian biopharmaceutical company, has successfully completed a reverse share split at a...
4 days ago
Bergenbio ASA share target raised, retains Buy rating on Q1 financial results By Investing.com
Investing.com
On Thursday, H.C. Wainwright adjusted its stock price target for Bergenbio ASA (BGBIO:NO), a Norwegian biopharmaceutical company,...
1 week ago
Companies Like BerGenBio (OB:BGBIO) Could Be Quite Risky
Simply Wall Street
We can readily understand why investors are attracted to unprofitable companies. For example, although...
5 days ago
BerGenBio Advances Lung Cancer Therapy Research - TipRanks.com
Tipranks
BerGenBio AS (BRRGF) has released an update. BerGenBio ASA has announced a partnership with Mays Cancer Center and Sobi® to study bemcentinib,...
1 week ago
Here's Why BerGenBio (OB:BGBIO) Must Use Its Cash Wisely
Simply Wall Street
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
6 months ago
Bemcentinib Earns FDA Fast Track Designation for AXL+ NSCLC
Cancer Network
Bemcentinib plus PD-1/L1 inhibition moves forward as therapy for patients with AXL-expressing non–small cell lung cancer.
35 months ago
Piramal Pharma Solutions Announces Collaboration With BerGenBio on the Development of FDA Fast Track ...
PR Newswire
PRNewswire/ -- Piramal Enterprises Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO)...
54 months ago
Bemcentinib for NSCLC Granted FDA Fast Track Designation
Targeted Oncology
Bemcentinib is currently being studied in combination with pembrolizumab and has demonstrated a good safety profile.
30 months ago
University of Iowa virology research helps facilitate new clinical trial for COVID-19
University of Iowa Hospitals and Clinics
Research by University of Iowa virologist Wendy Maury, PhD, has helped facilitate the launch of a new clinical trial in the United Kingdom...
49 months ago
BerGenBio: Encouraging I-O clinical data with selective AXL inhibitor bemcentinib (BGB324) supports its potential as ...
Cision News
Favourable interim safety data reported across three phase II clinical trials with bemcentinib in combination with KEYTRUDA® (pembrolizumab)...
76 months ago